EEL assay overcomes well-known limitations in spatial biology Rebus Biosystems Inc, ("Rebus Bio", "Rebus"), an Illumina Ventures-backed life science technology company creating revolutionary tools
Rebus Biosystems Continues Rapid Expansion of Scientific Team prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Credit: Stefan Zimmerman
New research at Karolinska Institutet in Sweden suggests a link between psychosis and a genetic change that affects the brain s immune system. The study published in
Molecular Psychiatry may impact the development of modern medicines for bipolar disorder or schizophrenia.
Psychosis affects approximately 2-3 per cent of the population and is characterized by a change in the perception of reality, often with elements of hallucinations and paranoid reactions.
Most of the people affected are patients with schizophrenia, but people with bipolar disorder may also experience psychotic symptoms.
The antipsychotics available today often have insufficient efficacy, and for patients, their life situation can be difficult.